In vitro and in vivo neuroprotective effects of cJun N-terminal kinase inhibitors on retinal ganglion cells
2016 · Molecular Neurodegeneration · 63 citations
https://doi.org/10.1186/s13024-016-0093-4
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
180
Papers
5.3K
Citations
37
h-index
82
i10-index
Robert J. Wordinger is an academic researcher from University of North Texas. The author has contributed to research in topics: Glaucoma and retinal disorders & Retinal Development and Disorders & TGF-β signaling in diseases. The author has an h-index of 37, co-authored 153 publications.
ORCID: 0000-0002-2861-8967https://doi.org/10.1186/s13024-016-0093-4
https://doi.org/10.1186/1750-1326-9-14
Click to start Chat